publicationMetadata:
  pmid: "24040940"
  title: "Molecular-guided therapy predictions reveal drug resistance phenotypes and treatment alternatives in malignant peripheral nerve sheath tumors."
  queryType: "bench"
  publicationType: "Lab Research"
  publicationTypeConfidence: 1.0
  hasMethodsSection: Yes
  likelyContainsTools: Yes
  expectedToolTypes: |
    Lab Research publication - Expected tool types:
    - Cell lines (MPNST-derived and neurofibroma-derived for in vitro experiments)
    - Antibodies (for immunofluorescence staining)
    - Computational tools (microarray analysis software, statistical tools)
    - Genetic reagents (primers for qRT-PCR, molecular biology reagents)
    
    This publication involves extensive laboratory work including microarray analysis, cell culture,
    quantitative PCR, immunofluorescence, and drug screening assays. Multiple tool types are expected
    across all categories except animal models, organoids, PDX models, and clinical assessment tools.
  overallAssessment: |
    This is a comprehensive laboratory research study investigating drug resistance mechanisms in MPNST
    using molecular-guided therapy prediction. The study involves extensive experimental work with cell
    lines, molecular biology techniques, and computational analysis. Research tools are essential for
    all aspects of this work and should be abundant throughout the methods and results sections.

toolValidations: []

potentiallyMissedTools:
  - toolName: "NF96.2"
    toolType: "cell_line"
    foundIn: "methods"
    contextSnippet: "MPNST-derived cell lines NF96.2, NF02.2, and NF94.3 (ATCC) and benign neurofibroma cell lines were maintained in 5% CO2 at 37C"
    whyMissed: "Standard cell line nomenclature with ATCC source - should be caught by cell line patterns"
    confidence: 1.0
    shouldBeAdded: Yes

  - toolName: "NF02.2"
    toolType: "cell_line"
    foundIn: "methods"
    contextSnippet: "MPNST-derived cell lines NF96.2, NF02.2, and NF94.3 (ATCC) and benign neurofibroma cell lines were maintained in 5% CO2 at 37C"
    whyMissed: "Standard cell line nomenclature with ATCC source - should be caught by cell line patterns"
    confidence: 1.0
    shouldBeAdded: Yes

  - toolName: "NF94.3"
    toolType: "cell_line"
    foundIn: "methods"
    contextSnippet: "MPNST-derived cell lines NF96.2, NF02.2, and NF94.3 (ATCC) and benign neurofibroma cell lines were maintained in 5% CO2 at 37C"
    whyMissed: "Standard cell line nomenclature with ATCC source - should be caught by cell line patterns"
    confidence: 1.0
    shouldBeAdded: Yes

  - toolName: "MS37T"
    toolType: "cell_line"
    foundIn: "methods"
    contextSnippet: "Quantitative real-time PCR confirms elevated expression in NF02.2 compared to benign neurofibroma-derived cell lines MS37T, MS80T, and MS90T"
    whyMissed: "Cell line nomenclature - benign neurofibroma-derived cell lines used as controls"
    confidence: 0.9
    shouldBeAdded: Yes

  - toolName: "MS80T"
    toolType: "cell_line"
    foundIn: "methods"
    contextSnippet: "Quantitative real-time PCR confirms elevated expression in NF02.2 compared to benign neurofibroma-derived cell lines MS37T, MS80T, and MS90T"
    whyMissed: "Cell line nomenclature - benign neurofibroma-derived cell lines used as controls"
    confidence: 0.9
    shouldBeAdded: Yes

  - toolName: "MS90T"
    toolType: "cell_line"
    foundIn: "methods"
    contextSnippet: "Quantitative real-time PCR confirms elevated expression in NF02.2 compared to benign neurofibroma-derived cell lines MS37T, MS80T, and MS90T"
    whyMissed: "Cell line nomenclature - benign neurofibroma-derived cell lines used as controls"
    confidence: 0.9
    shouldBeAdded: Yes

  - toolName: "ABCC1 antibody"
    toolType: "antibody"
    foundIn: "methods"
    contextSnippet: "incubated in primary antibodies against ABCC1 (Abcam ab24102) and S100 (Dako Z0311) at 1:50 and 1:400 dilution"
    whyMissed: "Antibody with vendor and catalog number - should be caught by antibody patterns"
    confidence: 1.0
    shouldBeAdded: Yes

  - toolName: "S100 antibody"
    toolType: "antibody"
    foundIn: "methods"
    contextSnippet: "incubated in primary antibodies against ABCC1 (Abcam ab24102) and S100 (Dako Z0311) at 1:50 and 1:400 dilution"
    whyMissed: "Antibody with vendor and catalog number - should be caught by antibody patterns"
    confidence: 1.0
    shouldBeAdded: Yes

  - toolName: "Alexa Fluor-488 Donkey anti-Mouse IgG"
    toolType: "antibody"
    foundIn: "methods"
    contextSnippet: "secondary incubations were conducted for 45 minutes at room temperature with respective Alexa Fluor-488 Donkey anti-Mouse IgG and Alexa Fluor-568 Donkey anti-Rabbit IgG"
    whyMissed: "Secondary antibody with specific fluorophore - should be caught by antibody patterns"
    confidence: 1.0
    shouldBeAdded: Yes

  - toolName: "Alexa Fluor-568 Donkey anti-Rabbit IgG"
    toolType: "antibody"
    foundIn: "methods"
    contextSnippet: "secondary incubations were conducted for 45 minutes at room temperature with respective Alexa Fluor-488 Donkey anti-Mouse IgG and Alexa Fluor-568 Donkey anti-Rabbit IgG"
    whyMissed: "Secondary antibody with specific fluorophore - should be caught by antibody patterns"
    confidence: 1.0
    shouldBeAdded: Yes

  - toolName: "Affymetrix expression console MAS 5.0"
    toolType: "computational_tool"
    foundIn: "methods"
    contextSnippet: "Microarray data was analyzed using Affymetrix expression console MAS 5.0 method"
    whyMissed: "Software with version number for microarray analysis - should be caught by computational tool patterns"
    confidence: 1.0
    shouldBeAdded: Yes

  - toolName: "XenoBase"
    toolType: "computational_tool"
    foundIn: "methods"
    contextSnippet: "Heat maps were generated using XenoBase® version 3.5 from Affymetrix array data using MAS 5.0 normalization"
    whyMissed: "Software with version number for data analysis - should be caught by computational tool patterns"
    confidence: 1.0
    shouldBeAdded: Yes

  - toolName: "StepOne Software"
    toolType: "computational_tool"
    foundIn: "methods"
    contextSnippet: "Melt curve analyses are performed following all reactions to ensure detection of a single product based upon single and consistent melting temperatures for each primer set using StepOne Software v2.3"
    whyMissed: "Software with version number for qRT-PCR analysis - should be caught by computational tool patterns"
    confidence: 1.0
    shouldBeAdded: Yes

  - toolName: "GeneGo"
    toolType: "computational_tool"
    foundIn: "methods"
    contextSnippet: "Most significant probe sets of top 100 and top 200 probes were submitted to GeneGo for extensive network and pathway enrichment analysis"
    whyMissed: "Bioinformatics analysis software - should be caught by computational tool patterns"
    confidence: 1.0
    shouldBeAdded: Yes

  - toolName: "PGSEA"
    toolType: "computational_tool"
    foundIn: "methods"
    contextSnippet: "Z-score expression values were also supplied to two drug response pattern evaluation methods, PGSEA and CMAP"
    whyMissed: "Bioinformatics analysis method - should be caught by computational tool patterns"
    confidence: 0.9
    shouldBeAdded: Yes

  - toolName: "CMAP"
    toolType: "computational_tool"
    foundIn: "methods"
    contextSnippet: "Z-score expression values were also supplied to two drug response pattern evaluation methods, PGSEA and CMAP"
    whyMissed: "Bioinformatics analysis method - should be caught by computational tool patterns"
    confidence: 0.9
    shouldBeAdded: Yes

  - toolName: "TRIzol reagent"
    toolType: "genetic_reagent"
    foundIn: "methods"
    contextSnippet: "Total RNA was extracted from cultured MPNST cell lines and benign neurofibroma-derived cell lines during logarithmic cell growth using TRIzol reagent (Invitrogen)"
    whyMissed: "RNA extraction reagent with vendor - should be caught by genetic reagent patterns"
    confidence: 1.0
    shouldBeAdded: Yes

  - toolName: "High Capacity cDNA Reverse Transcription Kit"
    toolType: "genetic_reagent"
    foundIn: "methods"
    contextSnippet: "Synthesis of cDNA was performed using 500 ng of RNA according to manufacturer's instructions (High Capacity cDNA Reverse Transcription Kit, Invitrogen)"
    whyMissed: "Molecular biology kit with vendor - should be caught by genetic reagent patterns"
    confidence: 1.0
    shouldBeAdded: Yes

  - toolName: "Sybr Select master mix"
    toolType: "genetic_reagent"
    foundIn: "methods"
    contextSnippet: "Reactions were performed in duplicate at 10 μl volume using Sybr Select master mix (Applied Biosystems) according to manufacturer's instructions"
    whyMissed: "qRT-PCR reagent with vendor - should be caught by genetic reagent patterns"
    confidence: 1.0
    shouldBeAdded: Yes

  - toolName: "NuGen Ovation Pico WTA System"
    toolType: "genetic_reagent"
    foundIn: "methods"
    contextSnippet: "Purified RNA was used for the preparation of amplified cDNA (NuGen Ovation Pico WTA System)"
    whyMissed: "Molecular biology system/kit - should be caught by genetic reagent patterns"
    confidence: 1.0
    shouldBeAdded: Yes

  - toolName: "NuGen Encore Biotin Module"
    toolType: "genetic_reagent"
    foundIn: "methods"
    contextSnippet: "Amplified cDNA was then fragmentated and labelled (NuGen Encore Biotin Module) and hybridized to GeneChip Human Genome U133 Plus 2.0 Array"
    whyMissed: "Molecular biology module/kit - should be caught by genetic reagent patterns"
    confidence: 1.0
    shouldBeAdded: Yes

suggestedPatterns:
  - patternType: "naming_convention"
    pattern: "NF[0-9]{2,3}\\.[0-9]+"
    toolType: "cell_line"
    examples: ["NF96.2", "NF02.2", "NF94.3"]
    reasoning: "MPNST-derived cell line naming convention with NF prefix followed by numbers and decimal point"

  - patternType: "naming_convention"
    pattern: "MS[0-9]{2,3}T"
    toolType: "cell_line"
    examples: ["MS37T", "MS80T", "MS90T", "MS135T", "MS142T", "MS153T", "MS156T"]
    reasoning: "Neurofibroma-derived cell line naming convention with MS prefix, numbers, and T suffix"

  - patternType: "context_phrase"
    pattern: "antibodies against .+ \\([A-Za-z]+ [a-z0-9]+\\)"
    toolType: "antibody"
    examples: ["antibodies against ABCC1 (Abcam ab24102)", "antibodies against S100 (Dako Z0311)"]
    reasoning: "Antibody mentions with vendor and catalog number in parentheses"

  - patternType: "context_phrase"
    pattern: "Alexa Fluor-[0-9]+ .+ anti-.+ IgG"
    toolType: "antibody"
    examples: ["Alexa Fluor-488 Donkey anti-Mouse IgG", "Alexa Fluor-568 Donkey anti-Rabbit IgG"]
    reasoning: "Secondary antibody naming pattern with Alexa Fluor fluorophore specification"

  - patternType: "term"
    pattern: "expression console MAS [0-9]+\\.[0-9]+"
    toolType: "computational_tool"
    examples: ["Affymetrix expression console MAS 5.0"]
    reasoning: "Microarray analysis software with version number"

  - patternType: "context_phrase"
    pattern: "using .+ v[0-9]+\\.[0-9]+"
    toolType: "computational_tool"
    examples: ["using StepOne Software v2.3", "using XenoBase® version 3.5"]
    reasoning: "Software usage with version specification"

  - patternType: "context_phrase"
    pattern: "submitted to [A-Z]+ for .+ analysis"
    toolType: "computational_tool"
    examples: ["submitted to GeneGo for extensive network and pathway enrichment analysis"]
    reasoning: "Bioinformatics analysis platform usage"

  - patternType: "context_phrase"
    pattern: "using .+ reagent \\([A-Za-z]+\\)"
    toolType: "genetic_reagent"
    examples: ["using TRIzol reagent (Invitrogen)"]
    reasoning: "Molecular biology reagent with vendor specification"

  - patternType: "context_phrase"
    pattern: ".+ Kit, [A-Za-z]+"
    toolType: "genetic_reagent"
    examples: ["High Capacity cDNA Reverse Transcription Kit, Invitrogen"]
    reasoning: "Molecular biology kit with vendor name"

  - patternType: "context_phrase"
    pattern: "using .+ master mix \\([A-Za-z ]+\\)"
    toolType: "genetic_reagent"
    examples: ["using Sybr Select master mix (Applied Biosystems)"]
    reasoning: "PCR/qRT-PCR master mix with vendor specification"

observations:
  - resourceName: "NF02.2"
    resourceType: "Cell Line"
    observationType: "Cellular"
    observationTypeOntologyId: "MP:0005384"
    details: |
      NF02.2 MPNST-derived cell line showed high ABCC1 expression confirmed by quantitative real-time PCR 
      relative to benign neurofibroma-derived cell lines. ABCC1 protein was detectable by immunofluorescent 
      staining in culture. This high expression serves as a predicted contra-indication for doxorubicin 
      therapy in these cells.
    foundIn: "results"
    contextSnippet: "NF02.2, an MPNST-derived cell line (ATCC) showed significant and consistent expression of ABCC1. Quantitative real-time PCR confirms the high level of expression of ABCC1 in the NF02.2 cell line relative to benign neurofibroma-derived cells"
    confidence: 1.0
    doi: "10.1186/1479-5876-11-213"

  - resourceName: "NF02.2"
    resourceType: "Cell Line"
    observationType: "Cellular"
    observationTypeOntologyId: "MP:0005384"
    details: |
      Doxorubicin resistance was observed in NF02.2 cells with significantly higher EC50 values 
      (0.861 μg/ml ± 0.17) compared to treatment with verapamil combination (0.248 μg/ml ± 0.07, p = 0.0002). 
      This demonstrates functional ABC transporter-mediated drug efflux contributing to chemotherapy resistance.
    foundIn: "results"
    contextSnippet: "Significantly lower doxorubicin EC50 values are obtained when doxorubicin dose is combined with verapamil (0.861 μg/ml ± 0.17 versus 0.248 μg/ml ± 0.07, p = 0.0002 with paired Student's t-test"
    confidence: 1.0
    doi: "10.1186/1479-5876-11-213"

  - resourceName: "NF94.3"
    resourceType: "Cell Line"
    observationType: "Cellular"
    observationTypeOntologyId: "MP:0005384"
    details: |
      NF94.3 cells showed high ABCC1 expression detectable by immunofluorescence and a small but significant 
      effect of verapamil on doxorubicin EC50 (0.81 μg/ml ± 0.42 versus 0.34 μg/ml ± 0.20, p = 0.025), 
      indicating moderate ABC transporter activity contributing to drug resistance.
    foundIn: "results"
    contextSnippet: "In NF94.3, similar to NF02.2, high ABCC1 expression is highlighted by the molecular-guided therapy analysis as a hypothetical doxorubicin resistance mechanism... A small effect of verapamil channel blockade on doxorubicin EC50 is observed in NF94.3 cells"
    confidence: 1.0
    doi: "10.1186/1479-5876-11-213"

  - resourceName: "NF96.2"
    resourceType: "Cell Line"
    observationType: "Cellular"
    observationTypeOntologyId: "MP:0005384"
    details: |
      NF96.2 cells showed low ABCC1 expression not detectable by immunofluorescence and no significant 
      effect of verapamil on doxorubicin EC50 (0.44 μg/ml ± 0.31 versus 0.22 μg/ml ± 0.25, p = 0.16), 
      indicating minimal ABC transporter-mediated drug resistance in this cell line.
    foundIn: "results"
    contextSnippet: "whereas NF96.2 is not flagged for high ABCC1 expression. ABCC1 is detectable by immunofluorescence in NF94.3 but not NF96.2... no significant effect is observed in low-ABCC1 expressing NF96.2 cells"
    confidence: 1.0
    doi: "10.1186/1479-5876-11-213"

  - resourceName: "Affymetrix expression console MAS 5.0"
    resourceType: "Computational Tool"
    observationType: "Usage Instructions"
    observationTypeOntologyId: ""
    details: |
      Microarray data was successfully normalized using Affymetrix expression console MAS 5.0 method. 
      Data was further filtered to remove probes with absent calls and expression intensities less than 100 
      in over 40% of samples. This normalization method was effective for comparative analysis between 
      MPNST and neurofibroma samples.
    foundIn: "methods"
    contextSnippet: "Array data was normalized using Affymetrix expression console MAS 5.0 method and further filtered to remove probes with absent calls and expression intensities less than 100 in over 40% of samples"
    confidence: 0.9
    doi: "10.1186/1479-5876-11-213"

  - resourceName: "XenoBase"
    resourceType: "Computational Tool"
    observationType: "Usage Instructions"
    observationTypeOntologyId: ""
    details: |
      XenoBase® version 3.5 was used successfully for generating heat maps from Affymetrix array data 
      using MAS 5.0 normalization. Clustering was performed in both sample and probe dimensions using 
      average linkages with a Pearson correlation distance metric, enabling visualization of expression 
      patterns across MPNST and neurofibroma samples.
    foundIn: "methods"
    contextSnippet: "Heat maps were generated using XenoBase® version 3.5 from Affymetrix array data using MAS 5.0 normalization. Clustering was performed in both sample and probe dimensions using average linkages with a Pearson correlation distance metric"
    confidence: 0.9
    doi: "10.1186/1479-5876-11-213"

  - resourceName: "ABCC1 antibody"
    resourceType: "Antibody"
    observationType: "Usage Instructions"
    observationTypeOntologyId: ""
    details: |
      ABCC1 antibody (Abcam ab24102) was used successfully at 1:50 dilution for immunofluorescence staining 
      of MPNST-derived cell lines. The antibody showed specific staining in high ABCC1-expressing cell lines 
      (NF02.2, NF94.3) but not in low-expressing lines (NF96.2), demonstrating good specificity for 
      detecting ABCC1 protein expression differences.
    foundIn: "results"
    contextSnippet: "incubated in primary antibodies against ABCC1 (Abcam ab24102) and S100 (Dako Z0311) at 1:50 and 1:400 dilution, respectively... ABCC1 is detectable by immunofluorescence in NF94.3 but not NF96.2"
    confidence: 0.9
    doi: "10.1186/1479-5876-11-213"

  - resourceName: "S100 antibody"
    resourceType: "Antibody"
    observationType: "Usage Instructions"
    observationTypeOntologyId: ""
    details: |
      S100 antibody (Dako Z0311) was used successfully at 1:400 dilution for immunofluorescence co-staining 
      with ABCC1 in MPNST-derived cell lines. The antibody provided reliable cell identification and 
      morphological context for ABCC1 expression analysis in both high and low expressing cell lines.
    foundIn: "methods"
    contextSnippet: "incubated in primary antibodies against ABCC1 (Abcam ab24102) and S100 (Dako Z0311) at 1:50 and 1:400 dilution, respectively, overnight at 4°C"
    confidence: 0.8
    doi: "10.1186/1479-5876-11-213"

summary:
  totalToolsMined: 0
  toolsAccepted: 0
  toolsRejected: 0
  toolsUncertain: 0
  potentiallyMissedCount: 20
  newPatternsCount: 10
  observationsExtracted: 8
  observationsByType:
    Cellular: 4
    Usage Instructions: 4
  majorIssuesFound: |
    - CRITICAL: Complete mining failure - 0 tools extracted from a tool-rich laboratory research publication
    - 20 clear research tools were missed including cell lines with ATCC sources, antibodies with catalog numbers, and computational tools with version numbers
    - Cell lines: 6 MPNST and neurofibroma-derived lines used extensively throughout the study
    - Antibodies: 4 antibodies including primary and secondary antibodies with vendor information
    - Computational tools: 6 software tools for microarray analysis, qRT-PCR, and bioinformatics
    - Genetic reagents: 4 molecular biology reagents and kits with vendor specifications
    - All missed tools have clear experimental usage context and vendor/source information
  recommendations: |
    URGENT: This represents a complete failure of the mining system for a publication rich in research tools.
    
    IMMEDIATE ACTIONS NEEDED:
    1. Add all 20 identified tools to the database - they are clearly valid research tools with experimental usage
    2. Implement the 10 suggested patterns to catch similar tools in future mining
    3. Review mining algorithms for cell line detection (NF##.# and MS##T patterns)
    4. Review antibody detection patterns for vendor/catalog number formats
    5. Review computational tool detection for software with version numbers
    6. Review genetic reagent detection for kits and reagents with vendor information
    
    TOOL CATEGORIES COMPLETELY MISSED:
    - Cell lines: Standard nomenclature with ATCC sources should be easily detectable
    - Antibodies: Clear vendor and catalog number information should trigger detection
    - Computational tools: Software names with version numbers should be caught
    - Genetic reagents: Kits and reagents with vendor names should be detected
    
    OBSERVATIONS: 8 scientific observations were successfully extracted for the validated tools,
    demonstrating the value of proper tool identification for downstream analysis.
    
    This publication should serve as a test case for improving mining algorithms across all tool categories.
